A Genetic Risk Profile in Longitudinal Systemic Lupus Erythematosus (SLE) Cohorts
A Genetic Risk Profile in Longitudinal Systemic Lupus Erythematosus (SLE) Cohorts
批准号:
8249125
负责人:
Elizabeth E Brown
金额:
$34.1万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2013-03-31
关键词:
AccountingAddressAdmixtureAfricanAfrican AmericanAmericanAmerindianAutoimmune ProcessBiological MarkersBiostatistics CoreClinicalCollaborationsComplexDevelopmentEnrollmentEnvironmental Risk FactorEthnic OriginEuropeanEvaluationFosteringGenesGeneticGenetic EpistasisGenetic Predisposition to DiseaseGenetic RiskGoalsHispanicsIndividualInstitutionInvestigationJointsKidneyMexicoMorbidity - disease rateNorth AmericaOrganOutcomePatientsPhenotypePopulationPopulation StudyPrevalencePuerto RicoRaceRelative (related person)ResearchRheumatismSeveritiesSiteSystemic Lupus ErythematosusTexasTimeabstractingcohortcost effectivedesignethnic minority populationgenetic epidemiologyhealth disparityindexinginsightmeetingsmortalitynovelprogramstrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract. The goal of Project 4 is to delineate the complex interactions between genetic ancestry and
environmental factors in the rate of progression and severity of renal involvement and organ damage associated
with systemic lupus erythematosus (SLE). The hypothesis is that SLE patients with a greater percentage of
African or Amerindian ancestry genes both alone and in combination with environmental factors, including low
individual- and group-level SES constructs, have more severe and rapidly progressive SLE as defined by several
longitudinal clinical and soluble biomarker indices. To address this hypothesis, we intend to (1) use panels of
established ancestry informative markers (AIMs) to estimate the extent of individual admixture separately among
European American (EA), African American (AA), Hispanic [from Texas (H-TX), Puerto Rico (H-PR) and Mexico
(H-M)] SLE patients with and without renal involvement and organ damage after controlling for confounding
factors; (2) determine the extent to which the estimates of individual admixture among these groups relate to the
time to indices of renal involvement and organ damage; and (3) determine the extent to which individual- and
group-level SES constructs modify the effect (additive joint effects and epistasis) of individual admixture on the
presence/absence, time to and severity of renal involvement and organ damage among patients with SLE. Using
the expanded PROFILE cohort of current and newly enrolled SLE patients meeting 4 of 11 ACR criteria from the
participating 8 study sites in the continental US, Puerto Rico and Mexico, we intend to exploit targeted
independent and joint contributions of genetic ancestry, using well-characterized AIMs, and environmental (SES)
factors with the tempo of SLE progression. The pooled study population will represent the largest multi-ethnic
population to date of SLE patients, which will allow for a comprehensive evaluation of gene and environmental
influences that are dimorphic by race/ethnicity. This approach offers the best opportunity to rapidly exploit these
relationships and to provide novel insight into the course and outcome of SLE. Results from this longitudinal
investigation will address key questions for understanding the relative contributions of environmental factors and
genetic ancestry that may account for the disparate trends of SLE-related morbidities, severity and progression
that is observed among populations of African and Hispanic ancestries.
Relationship of Project with Overall PPG Priorities. The proposed research plan is designed to examine the
interactions between genetic ancestry markers and environmental factors in the rate of progression and severity
of SLE. This research plan will (1) maximize synergy between all four PPG projects as well as the Administrative
and Genetic Epidemiology and Biostatistics Cores thereby facilitating a rigorous evaluation of our stated specific
aims in a time and cost-effective manner, (2) increase collaboration between partner institutions, (3) foster the
continued development of an effective Rheumatic Diseases Research Program, (4) enhance research efforts
toward SLE-related health disparities and (5) provide novel insight to the genetic etiology of this enigmatic
autoimmune phenotype that is disproportionately more frequent and severe among ethnic minority populations. In
this capacity, this investigation may be used to ultimately narrow the gap in SLE morbidity and mortality that is
disparately observed between African Americans and Hispanic populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The UAB-ENhancing Research In Cancer-related Health professions (ENRICH) Program
-
批准号:10627587
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2023
-
负责人:Elizabeth E Brown
-
依托单位:
Impact of Genetic susceptibility along the continuum from MGUS to MM
-
批准号:10436093
-
项目类别:
-
资助金额:$69.49万
-
财政年份:2022
-
负责人:Elizabeth E Brown
-
依托单位:
Impact of Genetic susceptibility along the continuum from MGUS to MM (Supplement)
-
批准号:10627525
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2022
-
负责人:Elizabeth E Brown
-
依托单位:
Impact of Genetic susceptibility along the continuum from MGUS to MM
-
批准号:10612006
-
项目类别:
-
资助金额:$65.04万
-
财政年份:2022
-
负责人:Elizabeth E Brown
-
依托单位:
Epigenetic contribution to the excess risk of MGUS in African Americans
-
批准号:10215787
-
项目类别:
-
资助金额:$61.63万
-
财政年份:2021
-
负责人:Elizabeth E Brown
-
依托单位:
Epigenetic contribution to the excess risk of MGUS in African Americans
-
批准号:10405069
-
项目类别:
-
资助金额:$60.39万
-
财政年份:2021
-
负责人:Elizabeth E Brown
-
依托单位:
Epigenetic contribution to the excess risk of MGUS in African Americans
-
批准号:10615105
-
项目类别:
-
资助金额:$59.68万
-
财政年份:2021
-
负责人:Elizabeth E Brown
-
依托单位:
Characterization of the lupus nephritis microRNAome
-
批准号:10251046
-
项目类别:
-
资助金额:$51.15万
-
财政年份:2018
-
负责人:Elizabeth E Brown
-
依托单位:
The Role of Exosome Heparanase and miRNAs as Biomarkers for Myeloma
-
批准号:8771214
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2014
-
负责人:Elizabeth E Brown
-
依托单位:
Molecular characterization of myeloma and related asymptomatic precursor states
-
批准号:8722142
-
项目类别:
-
资助金额:$64.2万
-
财政年份:2014
-
负责人:Elizabeth E Brown
-
依托单位:
Association of genetic and autoantibody signatures with SLE clinical course
-
批准号:8917092
-
项目类别:
-
资助金额:$63.62万
-
财政年份:2014
-
负责人:Elizabeth E Brown
-
依托单位:
Molecular characterization of myeloma and related asymptomatic precursor states
-
批准号:9326231
-
项目类别:
-
资助金额:$104.34万
-
财政年份:2014
-
负责人:Elizabeth E Brown
-
依托单位:
Association of genetic and autoantibody signatures with SLE clinical course
-
批准号:8760162
-
项目类别:
-
资助金额:$67.37万
-
财政年份:2014
-
负责人:Elizabeth E Brown
-
依托单位:
Molecular characterization of myeloma and related asymptomatic precursor states
-
批准号:9064103
-
项目类别:
-
资助金额:$43.15万
-
财政年份:2014
-
负责人:Elizabeth E Brown
-
依托单位:
A genome-wide methylation study of epigenetic contributions to multiple myeloma
-
批准号:8192004
-
项目类别:
-
资助金额:$12.75万
-
财政年份:2011
-
负责人:Elizabeth E Brown
-
依托单位:
A genome-wide methylation study of epigenetic contributions to multiple myeloma
-
批准号:8298510
-
项目类别:
-
资助金额:$21.96万
-
财政年份:2011
-
负责人:Elizabeth E Brown
-
依托单位:
A Genetic Risk Profile in Longitudinal Systemic Lupus Erythematosus (SLE) Cohorts
-
批准号:7870370
-
项目类别:
-
资助金额:$40.65万
-
财政年份:2009
-
负责人:Elizabeth E Brown
-
依托单位:
Functional Genomic Determinants of B cell Homeostasis and Susceptibility to SLE
-
批准号:7669288
-
项目类别:
-
资助金额:$5.37万
-
财政年份:2008
-
负责人:Elizabeth E Brown
-
依托单位:
06 Cancer Control and Population Sciences Program
-
批准号:10362800
-
项目类别:
-
资助金额:$3.52万
-
财政年份:1997
-
负责人:Elizabeth E Brown
-
依托单位:
04 - Cancer Control and Population Sciences
-
批准号:10411030
-
项目类别:
-
资助金额:$6.81万
-
财政年份:1997
-
负责人:Elizabeth E Brown
-
依托单位:
海外基金